Literature DB >> 12834152

Multiple sclerosis.

Elliot M Frohman1.   

Abstract

Multiple sclerosis (MS) is the most common disabling neurologic disease of young people affecting between 350 and 450,000 individuals in the United States. Substantial advances have been made in the diagnostic assessment and treatment interventions over the last 10 years such that we are now able effectively to treat both the disease process and the associated symptomatic complaints associated with MS. Most patients consult with their primary care physician at the time when the first clinical manifestations of MS emerge. These physicians play a central role in the early identification and treatment of patients with MS. This article emphasizes the expanding diagnostic and therapeutic capabilities evolving for the MS patient and the crucial role played by primary care physicians in collaboration with neurologists in the coordination of the initial diagnostic and treatment plan.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834152     DOI: 10.1016/s0025-7125(03)00008-7

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  23 in total

Review 1.  Insight into multiple sclerosis.

Authors:  Kelli Wehman-Tubbs; Steven H Yale; Loren A Rolak
Journal:  Clin Med Res       Date:  2005-02

Review 2.  Exercise and brain health--implications for multiple sclerosis: Part II--immune factors and stress hormones.

Authors:  Lesley J White; Vanessa Castellano
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

3.  Meeting the needs of people with primary progressive multiple sclerosis, their families, and the health-care community.

Authors:  Nancy J Holland; Diana M Schneider; Robert Rapp; Rosalind C Kalb
Journal:  Int J MS Care       Date:  2011

4.  Accelerometry reveals differences in gait variability between patients with multiple sclerosis and healthy controls.

Authors:  Jessie M Huisinga; Martina Mancini; Rebecca J St George; Fay B Horak
Journal:  Ann Biomed Eng       Date:  2012-11-18       Impact factor: 3.934

5.  Tanshinone IIA Ameliorates CNS Autoimmunity by Promoting the Differentiation of Regulatory T Cells.

Authors:  Ye Gong; Yuan-Chu Liu; Xiao-Li Ding; Ying Fu; Lang-Jun Cui; Ya-Ping Yan
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

6.  Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners.

Authors:  Nicholas G Larocca
Journal:  Patient       Date:  2011       Impact factor: 3.883

7.  Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.

Authors:  Myla D Goldman; Robert W Motl; Richard A Rudick
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

8.  The impact of dynamic balance measures on walking performance in multiple sclerosis.

Authors:  Nora E Fritz; Rhul Evans R Marasigan; Peter A Calabresi; Scott D Newsome; Kathleen M Zackowski
Journal:  Neurorehabil Neural Repair       Date:  2014-05-01       Impact factor: 3.919

Review 9.  Exercise and multiple sclerosis.

Authors:  Lesley J White; Rudolph H Dressendorfer
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

10.  T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis.

Authors:  Bradley N Martin; Chenhui Wang; Cun-jin Zhang; Zizhen Kang; Muhammet Fatih Gulen; Jarod A Zepp; Junjie Zhao; Guanglin Bian; Jeong-su Do; Booki Min; Paul G Pavicic; Caroline El-Sanadi; Paul L Fox; Aoi Akitsu; Yoichiro Iwakura; Anasuya Sarkar; Mark D Wewers; William J Kaiser; Edward S Mocarski; Marc E Rothenberg; Amy G Hise; George R Dubyak; Richard M Ransohoff; Xiaoxia Li
Journal:  Nat Immunol       Date:  2016-03-21       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.